Le Lézard
Classified in: Health, Science and technology

2020 Global Hematology and Flow Cytometry Markets - Abbott, CellaVision, Roche & Siemens Healthineers - ResearchAndMarkets.com


The "2020 Global Hematology and Flow Cytometry Markets: Supplier Shares by Country, Emerging Tests and Strategic Profiles of Leading Competitors" report has been added to ResearchAndMarkets.com's offering.

This 106-page report presents an overview of the clinical significance and market needs for major hematology and flow cytometry procedures.

The report also presents strategic assessments of current and emerging suppliers of hematology and flow cytometry products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/5i1rn5


These press releases may also interest you

at 18:50
NCPDP Foundation Funds New Project to Streamline REMS Process for the Industry
Getting specialty medications into...

at 18:30
Arthrex Wins Both Gold and Silver Medals at 2024 Edison Awards
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Riding the Trend: Baros Maldives' Immersive Water Therapy
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
NCPDP's National Facilitator Model Pilot Project Enters Second Phase
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Provides an Update on Application for Management Cease Trade Order
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

More news about Health...


News published on and distributed by: